Covid-19 Pill Access at Risk as Pharmacies Push for Bigger Payments
The Wall Street Journal
The rollout of new Covid-19 pills has exposed a potentially costly hole in how the government and healthcare companies are managing the pandemic drug response. Pharmacies that dispense the pills are pushing back and some are threatening to halt supplies if they don’t get more funds to cover the gap. The government paid billions of dollars for the pills, Paxlovid from Pfizer Inc. and molnupiravir from Merck & Co. and Ridgeback Biotherapeutics LP. Yet it left the details of how much pharmacists should be paid for filling prescriptions to health insurers and prescription-processing middlemen known as pharmacy-benefit managers. The commercial firms are paying pharmacies as low as a penny to about $10 for filling each prescription, according to pharmacists and pharmacy-transaction records reviewed by The Wall Street Journal.
For the full article, please visit The Wall Street Journal.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.